Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tight junction protein complex in the intestinal epithelium refers to a dynamic, multiprotein structure located at the apical region between neighboring epithelial cells. It includes transmembrane proteins such as claudins, occludin, junctional adhesion molecules (JAMs), and tricellulin, as well as cytosolic scaffold proteins such as zonula occludens-1, -2, and -3 (ZO-1/2/3). These proteins collectively seal the space between cells to control paracellular passage of ions, nutrients, water, and macromolecules, thereby maintaining the integrity of the intestinal barrier and protecting against luminal pathogens and toxins[1][2][3][4]. Dysregulation or disruption of this complex is implicated in various gastrointestinal, metabolic, and systemic diseases. Although currently there are no clinically approved drugs specifically targeting these complexes, restoration of tight junction integrity remains a major therapeutic goal in conditions characterized by barrier dysfunction. **Note on correctness:** - **is_incorrect: true** because "Tight junction proteins in intestinal epithelium" refers to a *complex/multi-protein system* and *not a single, discrete molecular target*. The term collectively applies to a family of distinct proteins (e.g., claudin-1, occludin, JAM-A, ZO-1) each of which has unique canonical names/abbreviations. For structured data or drug discovery, it is usually preferable to refer to one specific protein (e.g., "Claudin-1", "Occludin") rather than the entire complex[1][2][3].
Enhancement or stabilization of tight junction protein expression or arrangement (e.g., by MLCK inhibition, anti-inflammatory agents, nutritional compounds) Blockade or reduction of cytokine-induced tight junction disruption
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tight junction protein complex in intestinal epithelium.